Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Inspire Medical Systems

DB:2DR
Snowflake Description

Excellent balance sheet with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
2DR
DB
$1B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). The last earnings update was 35 days ago. More info.


Add to Portfolio Compare Print
  • Inspire Medical Systems has significant price volatility in the past 3 months.
2DR Share Price and Events
7 Day Returns
25%
DB:2DR
4.1%
DE Healthcare Services
7.3%
DE Market
1 Year Returns
12.4%
DB:2DR
0.9%
DE Healthcare Services
-17.7%
DE Market
2DR Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Inspire Medical Systems (2DR) 25% -35.8% -22.7% 12.4% - -
DE Healthcare Services 4.1% -8.3% -18.1% 0.9% 24.9% 85.3%
DE Market 7.3% -17.9% -25.8% -17.7% -25.6% -29%
1 Year Return vs Industry and Market
  • 2DR outperformed the Healthcare Services industry which returned 0.9% over the past year.
  • 2DR outperformed the Market in Germany which returned -17.7% over the past year.
Price Volatility
Industry
5yr Volatility vs Market
Related Companies

Value

 Is Inspire Medical Systems undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Inspire Medical Systems. This is due to cash flow or dividend data being unavailable. The share price is €51.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Inspire Medical Systems's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Inspire Medical Systems's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:2DR PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $-1.40
NYSE:INSP Share Price ** NYSE (2020-03-30) in USD $60.15
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.1x
Germany Market PE Ratio Median Figure of 400 Publicly-Listed Companies 16.36x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Inspire Medical Systems.

DB:2DR PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:INSP Share Price ÷ EPS (both in USD)

= 60.15 ÷ -1.40

-43.07x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Inspire Medical Systems is loss making, we can't compare its value to the DE Healthcare Services industry average.
  • Inspire Medical Systems is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Inspire Medical Systems's expected growth come at a high price?
Raw Data
DB:2DR PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -43.07x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 8 Analysts
0%per year
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.29x
Germany Market PEG Ratio Median Figure of 254 Publicly-Listed Companies 1.2x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Inspire Medical Systems, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Inspire Medical Systems's assets?
Raw Data
DB:2DR PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $5.80
NYSE:INSP Share Price * NYSE (2020-03-30) in USD $60.15
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.88x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.43x
DB:2DR PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:INSP Share Price ÷ Book Value per Share (both in USD)

= 60.15 ÷ 5.80

10.37x

* Primary Listing of Inspire Medical Systems.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Inspire Medical Systems is overvalued based on assets compared to the DE Healthcare Services industry average.
X
Value checks
We assess Inspire Medical Systems's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Inspire Medical Systems has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Inspire Medical Systems expected to perform in the next 1 to 3 years based on estimates from 8 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
0%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Inspire Medical Systems expected to grow at an attractive rate?
  • Unable to compare Inspire Medical Systems's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.
Growth vs Market Checks
  • Unable to compare Inspire Medical Systems's earnings growth to the Germany market average as it is expected to be loss making during the next 1-3 years.
  • Inspire Medical Systems's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:2DR Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:2DR Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 8 Analysts 0%
DB:2DR Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 8 Analysts 24.2%
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 28.6%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8.5%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.3%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:2DR Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:2DR Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 266 -28 1
2022-12-31 192 -16 -38 4
2021-12-31 150 -27 -38 8
2020-12-31 114 -40 -47 8
2020-03-31
DB:2DR Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 82 -33 -33
2019-09-30 72 -29 -29
2019-06-30 64 -30 -25
2019-03-31 57 -23 -24
2018-12-31 51 -19 -22
2018-09-30 44 -19 -21
2018-06-30 38 -19 -21
2018-03-31 33 -17 -20
2017-12-31 29 -16 -18

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Inspire Medical Systems is not considered high growth as it is expected to be loss making for the next 1-3 years.
  • Inspire Medical Systems's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:2DR Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below

All data from Inspire Medical Systems Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2DR Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31 -1.10 -1.10 -1.10 1.00
2022-12-31 -1.44 -0.81 -1.96 4.00
2021-12-31 -1.51 -0.16 -2.30 7.00
2020-12-31 -1.91 -1.06 -2.93 7.00
2020-03-31
DB:2DR Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 -1.40
2019-09-30 -1.24
2019-06-30 -1.12
2019-03-31 -1.17
2018-12-31 -1.50
2018-09-30 -2.26
2018-06-30 -4.77
2018-03-31 -16.13
2017-12-31 -14.88

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Inspire Medical Systems will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Inspire Medical Systems's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Inspire Medical Systems has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Inspire Medical Systems performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Inspire Medical Systems's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Inspire Medical Systems does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Inspire Medical Systems's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Inspire Medical Systems's 1-year growth to the DE Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Inspire Medical Systems's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Inspire Medical Systems Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2DR Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 82.05 -33.24 90.47 12.84
2019-09-30 71.70 -28.94 78.38 11.22
2019-06-30 63.90 -25.39 69.41 9.37
2019-03-31 56.80 -23.59 61.88 8.26
2018-12-31 50.59 -21.83 53.53 7.39
2018-09-30 43.99 -21.30 47.66 6.92
2018-06-30 38.21 -20.63 42.37 6.32
2018-03-31 33.31 -19.53 36.94 6.33
2017-12-31 28.57 -17.51 32.36 6.19
2016-12-31 16.43 -18.53 22.68 7.09
2015-12-31 8.01 -21.34 17.92 7.08

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Inspire Medical Systems has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Inspire Medical Systems has efficiently used its assets last year compared to the DE Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Inspire Medical Systems improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Inspire Medical Systems's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Inspire Medical Systems has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Inspire Medical Systems's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Inspire Medical Systems's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Inspire Medical Systems is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Inspire Medical Systems's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Inspire Medical Systems's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Inspire Medical Systems Company Filings, last reported 3 months ago.

DB:2DR Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 139.84 24.52 149.47
2019-09-30 146.05 24.47 151.60
2019-06-30 152.49 24.42 158.62
2019-03-31 157.42 24.36 177.01
2018-12-31 164.00 24.93 188.21
2018-09-30 98.31 24.81 120.43
2018-06-30 102.58 24.70 123.96
2018-03-31 -3.96 24.57 17.90
2017-12-31 1.48 16.46 16.14
2016-12-31 -6.56 15.69 6.69
2015-12-31
  • Inspire Medical Systems's level of debt (17.5%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Inspire Medical Systems's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Inspire Medical Systems has sufficient cash runway for more than 3 years based on current free cash flow.
  • Inspire Medical Systems has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 14.6% each year.
X
Financial health checks
We assess Inspire Medical Systems's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Inspire Medical Systems has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Inspire Medical Systems's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Inspire Medical Systems dividends. Estimated to be 0% next year.
If you bought €2,000 of Inspire Medical Systems shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Inspire Medical Systems's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Inspire Medical Systems's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:2DR Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 1.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3.9%
Germany Minimum Threshold Dividend Yield 10th Percentile 1%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:2DR Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31 0.00 1.00
2021-12-31 0.00 2.00
2020-12-31 0.00 2.00
2020-03-31

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Inspire Medical Systems has not reported any payouts.
  • Unable to verify if Inspire Medical Systems's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Inspire Medical Systems's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Inspire Medical Systems has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Inspire Medical Systems's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Inspire Medical Systems's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Inspire Medical Systems afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Inspire Medical Systems has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Inspire Medical Systems's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Timothy Herbert
COMPENSATION $2,899,563
AGE 56
TENURE AS CEO 12.3 years
CEO Bio

Mr. Timothy P. Herbert has been Chief Executive Officer, President and Director of Inspire Medical Systems, Inc. since November 2007. He is the Founder of Inspire Medical Systems, Inc. Mr. Herbert has over 25 years of experience in new business development including over 11 years at Medtronic and 7 years at Inspire Medical Systems. He has held management positions in product development, clinical research, regulatory, sales, marketing, and healthcare reimbursement. He has been part of the Inspire business since 1996, assuming management of the venture in 1998. With extensive experience in venture development, as well as his detailed knowledge of the Inspire system, OSA disease state, and the sleep diagnostic and therapeutic market, he is well positioned to lead the Inspire organization. Mr. Herbert has a B.S. in Electrical Engineering from North Dakota State University and an M.B.A. from the University of St. Thomas.

CEO Compensation
  • Timothy's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Timothy's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Inspire Medical Systems management team in years:

1.2
Average Tenure
53
Average Age
  • The average tenure for the Inspire Medical Systems management team is less than 2 years, this suggests a new team.
Management Team

Timothy Herbert

TITLE
CEO, President & Director
COMPENSATION
$3M
AGE
56
TENURE
12.3 yrs

Rick Buchholz

TITLE
Chief Financial Officer
COMPENSATION
$1M
AGE
51
TENURE
5.8 yrs

Randy Ban

TITLE
Chief Commercial Officer
COMPENSATION
$2M
AGE
54
TENURE
1.2 yrs

John Rondoni

TITLE
Vice President of Product Development

Steve Jandrich

TITLE
VP of Human Resources & Chief Compliance Officer
AGE
52
TENURE
1.2 yrs

Martin Abrams

TITLE
VP of Marketing & Customer Experience
TENURE
1.2 yrs

Ivan Lubogo

TITLE
Senior Vice President of U.S. Sales
TENURE
0.2 yrs

Andreas Henke

TITLE
Senior Vice President of European Operations
TENURE
0.2 yrs

Kathy Sherwood

TITLE
Senior Vice President of Global Market Access
TENURE
0.2 yrs
Board of Directors Tenure

Average tenure and age of the Inspire Medical Systems board of directors in years:

10.8
Average Tenure
60
Average Age
  • The average tenure for the Inspire Medical Systems board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Marilyn Nelson

TITLE
Independent Chair of the Board & Lead Director
COMPENSATION
$192K
AGE
79
TENURE
3.3 yrs

Timothy Herbert

TITLE
CEO, President & Director
COMPENSATION
$3M
AGE
56
TENURE
12.3 yrs

Shawn McCormick

TITLE
Independent Director
COMPENSATION
$170K
AGE
55
TENURE
3.2 yrs

Casey Tansey

TITLE
Independent Director
COMPENSATION
$165K
AGE
61
TENURE
12.2 yrs

Gary Ellis

TITLE
Independent Director
COMPENSATION
$189K
AGE
61
TENURE
0.7 yrs

Chau Khuong

TITLE
Independent Director
COMPENSATION
$158K
AGE
43
TENURE
5.8 yrs

Dana Mead

TITLE
Independent Director
COMPENSATION
$160K
AGE
60
TENURE
11.7 yrs

Mudit Jain

TITLE
Independent Director
COMPENSATION
$160K
AGE
50
TENURE
10.8 yrs

Jerry Griffin

TITLE
Independent Director
COMPENSATION
$164K
AGE
74
TENURE
12.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
10. Mar 20 Sell OrbiMed Advisors LLC Company 06. Mar 20 06. Mar 20 -500,000 €73.76 €-36,878,256
05. Mar 20 Sell OrbiMed Advisors LLC Company 03. Mar 20 04. Mar 20 -500,000 €75.94 €-37,834,430
03. Mar 20 Sell U.S. Venture Partners Company 28. Feb 20 28. Feb 20 -70,000 €80.22 €-5,292,070
22. Aug 19 Sell Mudit Jain Individual 20. Aug 19 21. Aug 19 -1,250 €62.18 €-77,609
20. Aug 19 Sell Mudit Jain Individual 16. Aug 19 19. Aug 19 -2,240 €61.11 €-134,959
08. Jul 19 Sell GDN Holdings, LLC Company 03. Jul 19 08. Jul 19 -25,000 €59.72 €-1,475,790
04. Jun 19 Sell Amzak Health Investors, Llc Company 30. May 19 31. May 19 -66,568 €50.28 €-3,329,395
30. May 19 Sell Amzak Health Investors, Llc Company 24. May 19 29. May 19 -44,053 €48.87 €-2,148,395
24. May 19 Sell Amzak Health Investors, Llc Company 21. May 19 23. May 19 -39,379 €49.09 €-1,922,595
12. Apr 19 Sell GDN Holdings, LLC Company 10. Apr 19 10. Apr 19 -47,015 €49.04 €-2,305,499
X
Management checks
We assess Inspire Medical Systems's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Inspire Medical Systems has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.

Details
Name: Inspire Medical Systems, Inc.
2DR
Exchange: DB
Founded: 2007
$1,317,171,484
24,159,436
Website: http://www.inspiresleep.com
Address: Inspire Medical Systems, Inc.
5500 Wayzata Boulevard,
Suite 1600,
Golden Valley,
Minnesota, 55416,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE INSP Common Stock New York Stock Exchange US USD 03. May 2018
DB 2DR Common Stock Deutsche Boerse AG DE EUR 03. May 2018
Number of employees
Current staff
Staff numbers
239
Inspire Medical Systems employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/31 00:29
End of day share price update: 2020/03/30 00:00
Last estimates confirmation: 2020/03/30
Last earnings filing: 2020/02/25
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.